however , the program of btoc followed by multiple-site irradiation was associated with a higher incidence of severe or life-threatening thrombocytopenia ( 23 % versus 8 % for cav ) , accounted for almost entirely by patients receiving hepatic irradiation after chemotherapy , among whom the incidence of this complication ( grade 3 or 4 ) was 76 % and 14 % , respectively .
C0040034
thrombocytopenia
C0013089
cav